In vitro evaluation of Bifidobacterium strains of human origin for potential use in probiotic functional foods. (Q53118563)

11 May 2018

title

In vitro evaluation of Bifidobacterium strains of human origin for potential use in probiotic functional foods. (English)

1 reference

11 May 2018

0 references

0 references

0 references

T C Souza

1

1 reference

11 May 2018

A M Silva

2

1 reference

11 May 2018

J R P Drews

3

1 reference

11 May 2018

D A Gomes

4

1 reference

11 May 2018

C G Vinderola

5

1 reference

11 May 2018

J R Nicoli

6

1 reference

11 May 2018

publication date

1 June 2013

1 reference

11 May 2018

published in

Beneficial microbes

1 reference

11 May 2018

volume

4

1 reference

11 May 2018

issue

2

1 reference

11 May 2018

page(s)

179-186

1 reference

11 May 2018

Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antimicrobial proteinaceous compounds obtained from bifidobacteria: from production to their application.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Inhibitory effect of conjugated alpha-linolenic acid from bifidobacteria of intestinal origin on SW480 cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Susceptibility of Lactobacillus spp. to antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antimicrobial susceptibility profiles of 32 type strains of Lactobacillus, Bifidobacterium, Lactococcus and Streptococcus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Bifidobacteria can protect from enteropathogenic infection through production of acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Pediatric functional constipation treatment with Bifidobacterium-containing yogurt: a crossover, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Getting better with bifidobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Distinct Bifidobacterium strains drive different immune responses in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Resistance of potential probiotic lactic acid bacteria and bifidobacteria of African and European origin to antimicrobials: determination and transferability of the resistance genes to other bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Probiotics: an overview of beneficial effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Aerotolerance of human clinical isolates of Prevotella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Intrinsic tolerance of Bifidobacterium species to heat and oxygen and survival following spray drying and storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Cell viability and immunostimulating and protective capacities of Bifidobacterium longum 51A are differentially affected by technological variables in fermented milks

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

A Randomized Formula Controlled Trial of Bifidobacterium lactis and Streptococcus thermophilus for Prevention of Antibiotic-Associated Diarrhea in Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Influence of Isolation Site, Laboratory Handling and Growth Stage on Oxygen Tolerance of Fusobacterium Strains

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

Antagonism against Anaerobic and Facultative Bacteria through a Diffusible Inhibitory Compound Produced by aLactobacillus sp. Isolated from the Rat Fecal Microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0052

21 January 2018

Identifiers

DOI

10.3920/BM2012.0052

1 reference

11 May 2018

1 reference

11 May 2018